Harrow Inc (HROW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HROW | AUPH | ELVN | ||
| Company | Harrow Inc | Aurinia Pharm Ord | Enliven Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 35.16 | 9.57 | 24.29 | ||
| High | 35.95 | 9.60 | 24.30 | ||
| Low | 33.89 | 8.97 | 21.84 | ||
| Last | 34.08 | 9.10 | 22.50 | ||
| Change | -0.99 | -0.45 | -1.89 | ||
| % Change | -2.84% | -4.71% | -7.75% | ||
| Volume | 495,100 | 1,184,700 | 445,900 | ||
| 20-Day Average Volume | 378,915 | 1,568,625 | 186,120 | ||
| Previous Close | 35.08 | 9.55 | 24.39 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.39 | 9.13 | 24.19 | ||
| 20-Day Raw Stochastic | 1.80% | 43.12% | 16.91% | ||
| 20-Day Relative Strength | 35.70% | 55.56% | 40.58% | ||
| Weighted Alpha | +102.93 | +37.79 | -0.22 | ||
| Today's Opinion | 8% Sell | 88% Buy | 24% Sell | ||
| Previous Opinion | 8% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.70% since 12/11/24 | -9.99% since 12/11/24 | -6.56% since 12/11/24 | ||
| Low | 33.89 on 12/18/24 | 8.97 on 12/18/24 | 21.69 on 12/12/24 | ||
| High | 37.68 on 12/12/24 | 10.15 on 12/12/24 | 24.59 on 12/12/24 | ||
| 1-Month | |||||
| %Chg | -10.24% since 11/18/24 | +13.61% since 11/18/24 | -9.64% since 11/18/24 | ||
| Low | 33.89 on 12/18/24 | 7.89 on 11/19/24 | 21.69 on 12/12/24 | ||
| High | 44.45 on 11/22/24 | 10.67 on 12/10/24 | 26.48 on 11/20/24 | ||
| 3-Month | |||||
| %Chg | -24.82% since 09/18/24 | +28.53% since 09/18/24 | +3.40% since 09/18/24 | ||
| Low | 33.89 on 12/18/24 | 6.64 on 10/10/24 | 21.69 on 12/12/24 | ||
| High | 59.23 on 10/18/24 | 10.67 on 12/10/24 | 30.03 on 10/18/24 | ||
| 6-Month | |||||
| %Chg | +93.09% since 06/18/24 | +67.90% since 06/18/24 | +9.92% since 06/18/24 | ||
| Low | 19.31 on 06/20/24 | 5.20 on 08/06/24 | 19.88 on 06/26/24 | ||
| High | 59.23 on 10/18/24 | 10.67 on 12/10/24 | 30.03 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,249,196 | 1,367,360 | 1,191,671 | ||
| Shares Outstanding, K | 35,615 | 143,179 | 48,859 | ||
| Annual Sales | 130,190,000 | 175,510,000 | 0 | ||
| Annual Net Income | -24,410,000 | -78,020,000 | -71,580,000 | ||
| Last Quarter Sales | 49,260,000 | 67,770,000 | 0 | ||
| Last Quarter Net Income | -4,220,000 | 14,350,000 | -23,160,000 | ||
| 60-Month Beta | 0.69 | 1.41 | 1.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 11/13/24 | 0.10 on 11/07/24 | -0.48 on 11/13/24 | ||
| Latest Earnings Date | 11/13/24 | 11/07/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||